Introduction
============

The 14-3-3 protein family are highly conserved soluble acidic proteins ([@b1-ol-0-0-7283]). There are 7 isoforms (including β, ε, η, γ, τ, ζ and σ) in the 14-3-3 family, with molecular masses ranging between 28 and 33 kDa ([@b1-ol-0-0-7283]). The 14-3-3 proteins may function as adaptor molecules or scaffolds of protein-protein interactions, or act as localization anchors, controlling the subcellular localization of proteins, or as enzyme activity regulators, increasing or suppressing their catalytic activity ([@b2-ol-0-0-7283]). As a member of the 14-3-3 protein family, 14-3-3ε may integrate a number of signaling pathways by interacting with distinct proteins; therefore, 14-3-3ε serves functions in the regulation of the cell cycle ([@b3-ol-0-0-7283],[@b4-ol-0-0-7283]) and apoptosis ([@b5-ol-0-0-7283]--[@b8-ol-0-0-7283]). Previously, 14-3-3ε has been reported to bind with heat shock factor 1 (HSF1) through the extracellular signal regulated kinase/glycogen synthase kinase 3/14-3-3ε pathway, thus suppressing HSF1 activity during cellular proliferation ([@b9-ol-0-0-7283]). Zhong *et al* ([@b6-ol-0-0-7283]) demonstrated that inhibiting the interaction of 14-3-3ε with chloride intracellular channel protein 4 enhanced autophagy and contributed to mitochondrial and ER stress-induced apoptosis under starvation conditions. In addition, 14-3-3ε has an association with the occurrence and development of a number of types of tumor; for example, the expression of 14-3-3ε has been identified to be downregulated in gastric cancer ([@b10-ol-0-0-7283]) and pediatric astrocytoma ([@b11-ol-0-0-7283]), whereas it is upregulated in hepatocellular carcinoma ([@b12-ol-0-0-7283],[@b13-ol-0-0-7283]), renal cancer ([@b14-ol-0-0-7283]) and breast cancer ([@b15-ol-0-0-7283]).

Previous studies have revealed that certain isoforms of 14-3-3 protein family may inhibit cell apoptosis ([@b16-ol-0-0-7283]--[@b20-ol-0-0-7283]). In the present study, it was demonstrated that 14-3-3ε was a differentially expressed nuclear matrix component in MG-63 cells during apoptosis. The nuclear matrix is composed of the nuclear lamina, the nucleolar remnants and an internal nuclear mesh of fibers of an unknown constitution that it is possible to visualize by electron microscopy ([@b21-ol-0-0-7283]). Alteration of nuclear matrix protein composition was demonstrated to be involved in the apoptotic process ([@b22-ol-0-0-7283]). The present study revealed that 14-3-3ε was an altered nuclear matrix protein, suggesting that 14-3-3ε may be an important regulator in curcumin induced apoptosis. However, the regulatory mechanism of 14-3-3ε in cell carcinogenesis and apoptosis remains unknown. In the present study, further investigations were performed on the expression and localization of 14-3-3ε and its co-localization with apoptosis-associated proteins in order to improve the current understanding of 14-3-3ε function in the regulation of cellular carcinogenesis and apoptosis.

Materials and methods
=====================

### Materials

Human osteosarcoma MG-63 cells were purchased from Xiangya Central Experiment Laboratory (Changsha, China). Curcumin standards were purchased from Fuzhou Min Jian Medicine Inspection Service (Fuzhou, China).

### Cell culture and induction of apoptosis

Human osteosarcoma MG-63 cells were cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific Inc., Waltham, MA, USA) containing 10% fetal bovine serum (Zheijiang Tianhang Biotechnology Co., Inc., Hangzhou, China), 100 U/ml penicillin and 100 U/ml streptomycin, at 37°C in a humidified atmosphere containing 5% CO~2~. Induction of apoptosis was performed following a method described previously ([@b22-ol-0-0-7283]). Cells in the exponential phase were digested with 0.25% trypsin (Xiamen Lulong Biotech Development Co., Inc., Xiamen, China) and transferred to new plates. After 24 h, the medium was replaced with fresh RPMI-1640 medium with or without 7.5 µg/ml curcumin. Cells were incubated with curcumin at 37°C for 0--48 h and collected at the corresponding time.

### Selective extraction of nuclear matrix proteins (NMPs)

NMPs were extracted following a modified method described previously by Michishita *et al* ([@b23-ol-0-0-7283]). Selected cells were washed with PBS three times. Subsequently, cells were resuspended with cytoskeleton extraction buffer CSK100 \[10 mM Pipes, pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl~2~, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 0.5% Triton X-100\] and incubated on ice for 10 min. Lysates were centrifuged at 900 × g for 5 min at 4°C, and the resulting supernatant was discarded. The precipitate was washed with cytoskeleton extraction buffer CSK50 (10 mM Pipes, pH 6.8, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl~2~, 1 mM EGTA, 1 mM PMSF and 0.5% Triton X-100) twice. CSK50 containing 400 U/ml DNase I (Sangon Biotech Co., Ltd., Shanghai, China) was added to the precipitate prior to incubation at room temperature for 30 min. Subsequently, 1 M (NH4)~2~SO~4~ was added dropwise to the tube to a final concentration of 0.25 M. After 15 min of incubation at room temperature, NMPs were obtained by centrifugation at 900 × g for 5 min at 4°C. NMPs were washed with CSK50 once. The supernatant was removed and the proteins were stored at −80°C until use.

### Two-dimensional (2D) gel electrophoresis and mass spectrometry analysis

NMPs were re-dissolved in 2D sample buffer which containing 7 M urea, 2 M Tthiourea, 4% CHAPS, 40 mM Tris-base, 2% pharmalyte (pH 3--10), 40 mM DTT, 1 mM PMSF, 1 mM EDTA. The 2D PAGE process was performed following a previously described method ([@b24-ol-0-0-7283]). For first dimension separation, immobilized pH gradient (IPG) strips (11 cm, pH 4--7) were used and a total of 350 µg proteins were loaded, followed by isoelectric focusing electrophoresis according to the optimized procedure. IPG strips were rehydrated with the sample buffer containing 350 µg protein, and were then subjected to isoelectric focusing (IEF) using an Ettan IPGphor 3 IEF System (GE Healthcare, Chicago, IL, USA). The focus procedure was as follows: Step 1, 100 V slow ramp for 30 min; step 2, 200 V slow ramp for 30 min; step 3, 500 V slow ramp for 30 min; step 4, 1,000 V rapid ramp for 1 h; step 5, 8,000 V slow ramp for 4 h; step 6, 8,000 V rapid ramp for 40,000 V/h; step 7, a hold at 500 V. Following IEF, IPG strips were equilibrated in 6 M urea, 2% SDS, 50 mM Tris-HCl, pH 8.8, 20% v/v glycerol, and 2% DTT for 15 min and then, for an additional 15 min, placed in the same buffer but with DTT replaced by 2.5% iodoacetamide. The strips were then placed on 10% SDS-PAGE gels. Electrophoresis was performed at 10 mA/gel at 4°C overnight, followed by silver staining as previously described ([@b25-ol-0-0-7283]).

Gels were scanning using the GE ImageScanner III (GE Healthcare) and analyzed using PDQuest 8.0 software (Bio-Rad Laboratories, Inc., Hercules, CA, USA). When spots were detected in PDQuest, the original gel image was filtered and smoothed to clarify the spots, then three-dimensional Gaussian spots were created from the clarified spots. Spot quantity was defined as the total intensity of a defined spot in a gel image. The formula for calculating the quantity of Gaussian spots in PDQuest was as follows: Spot quantity=spot height × π × σx × σy. Spot height is the peak intensity of the Gaussian representation of the spot, measured in terms of optical density (OD). σx and σy are the standard deviation of the Gaussian distribution of the spot in the direction of the x- and y-axis, respectively, measured in IU (1 IU=100 µM). Protein spots with a fold change \>2 were defined as differential protein spots and subjected to matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) analysis.

Gel particles of differential protein spots were excised and subsequently destained with a solution containing 50% acetonitrile and 50 mM ammonium bicarbonate at room temperature several times, until the gel particles were colorless. The gel particles were dehydrated in 100% acetonitrile, followed with centrifugation under vacuum at 400 × g for 30 min at 42°C. Dehydrated particles were digested with trypsin (Promega Corporation, Madison, WI, USA) at 37°C for 16 h. The peptide fragments were extracted using 50% acetonitrile containing 5% trifluoroacetic acid (TFA). Samples were then dehydrated by centrifugation under vacuum at 400 × g for 30 min at 42°C.

Extracted peptide fragments were dissolved in 1 µl 0.1% TFA and then blended with an equal volume of a-cyano-4-hydroxycinnamic acid (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Samples were then spotted on a target plate. Following air-drying at room temperature, samples were analyzed using MALDI-TOF-MS (Reflex III MALDI-TOF; Bruker Daltonics, Leipzig, Germany). A 337 nm nitrogen laser was used to irradiate and ionize the samples with the pulse width set at 3 ns. The source 1 and source 2 accelerating voltage were set at 20 and 23 kV, respectively. The delay extraction time was 2,000 ns. The mass-to-charge ratios (m/z) were determined by the time of ions flying in the flight tube, and the peptide mass fingerprinting (PMF) was obtained.

PMF was interpreted and quantified by FlexAnalysis software 2.0 (Bruker Corporation, Ettlinger, Germany) following internal calibration with the trypsin autolysis products \[842.51 (M+H) and 2211.11 (M+H)\]. The data were mapped to corresponding proteins by searching against the SWISS-PROT ([@b26-ol-0-0-7283]) and National Center for Biotechnology Information databases ([@b27-ol-0-0-7283]) using the MASCOT search engine ([www.matrixscience.com](www.matrixscience.com)). Up to one missed cleavage was allowed for each peptide. Fixed modification was carbamidomethyl. Variable modification was oxidation. The max peptide tolerance was ±200 ppm. MH^+^ and monoisotopic were selected for mass values. Protein scores \>66 were deemed significant (P\<0.05).

### Western blot analysis

Cells were lysed using radioimmunoprecipitation assay buffer containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.5% SDS, 0.5% sodium deoxycholate, 1 mM PMSF and 1X protease inhibitor cocktail (S8830; Sigma-Aldrich; Merck KGaA) at 4°C for 30 min. Subsequently, the lysate was centrifuged at 12,000 × g for 15 min at 4°C. The Bradford assay was used to determine protein concentrations and, subsequently, the proteins (20 µg) were separated using 12% SDS-PAGE, and transferred onto a polyvinylidene difluoride (PVDF) membrane. The membrane was then blocked in 1X TBS containing 5% non-fat milk at room temperature for 1 h. The PVDF membrane was then incubated with primary antibodies against 14-3-3ε (cat. no. 11648-2-AP; ProteinTech Group, Inc., Chicago, IL, USA; cat. no. sc-393177; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) or β-actin (cat. no. 60008-1-Ig; ProteinTech Group, Inc.) at a dilution of 1:1,000 in 1X TBST (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.2% Tween20) at 4°C overnight. Following washing with 1X TBST 3 times (7 min per wash), the membrane was incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (cat. no. Pierce-31460; Thermo Fisher Scientific Inc.) or HRP-conjugated goat anti-mouse IgG (Pierce-31430; Thermo Fisher Scientific Inc.; diluted in 1X TBST at a dilution of 1:5,000) at room temperature for 1 h. The signals were detected using WesternBright™ enhanced chemiluminescence kit (cat. no. K-12045-D50; Advansta, Inc, Menlo Park, CA, USA). The results were analyzed using Quantity One software (version 4.6.2, Bio-Rad Laboratories, Inc.).

### Selective extraction of nuclear matrix intermediate fiber system and sample preparation

MG-63 cells were seeded on a 6-cm culture dish with a 13-mm coverslip in it. For the control group, \~4×10^3^ cells were seeded. For the curcumin-treated group, \~1×10^4^ cells were seeded, as cell growth was suppressed and certain cells died or detached during curcumin treatment. Following treatment for 36 h, coverslips with seeded MG-63 cells were washed twice with warm PBS (37°C). Subsequently, the cells were selectively extracted as previously described ([@b28-ol-0-0-7283]). Following selective extraction, the samples were fixed in 4% paraformaldehyde at 4°C for 20 min. For observation using light microscopy, samples were stained with Coomassie brilliant blue at room temperature for 30 min, followed by washing with double-distilled water several times. The samples were then observed by light microscopy under ×400 magnification. For observation using fluorescence microscopy, samples were subjected to immunofluorescent staining as subsequently described.

### Immunofluorescent staining (IF)

MG-63 cells were seeded on a 6-well culture plate with a 13-mm coverslip in each well. For the control group, \~2×10^3^ cells were seeded. For the curcumin treated group, \~5×10^3^ cells were seeded. Cells seeded on coverslips were rinsed in warm PBS three times, permeabilized in PBS (containing 0.5% Triton X-100) at 4°C for 20 min and fixed in 4% paraformaldehyde at 4°C for 10 min. After 1 h of blocking in 5% bovine serum album (A8020; Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) at room temperature, cells were incubated with specific primary antibodies at room temperature for 30 min and then at 4°C for overnight. The primary antibodies were as follows: Rabbit anti-14-3-3ε (1:50) (cat. no. 11648-2-AP; ProteinTech Group, Inc., Chicago, IL, USA)/mouse anti-Bcl-2-associated X protein (Bax; 1:100; cat. no. 60267-1-Ig; ProteinTech Group, Inc.), rabbit anti-14-3-3ε (1:50)/mouse anti-B-cell lymphoma 2 (Bcl-2; 1:100; cat. no. 60178-1-Ig; ProteinTech Group, Inc.), rabbit anti-14-3-3ε (1:50)/mouse anti-P53 (1:100; cat. no. 60283-1-Ig; ProteinTech Group, Inc.), muse anti-14-3-3ε (1:50; cat. no. sc-393177; Santa Cruz Biotechnology, Inc.)/rabbit anti-c-Fos (1:50; cat. no. 26192-1-AP; ProteinTech Group, Inc.), mouse anti-14-3-3ε (1:50)/rabbit anti-retinoblastoma (RB; 1:50; cat. no. 25628-1-AP; ProteinTech Group, Inc.). Following 3 washes (5 min per wash) at room temperature with PBS, cells were incubated with secondary antibodies mixture containing goat anti-mouse IgG labeled with fluorescein isothiocyanate (1:200; FITC; cat. no. P0196; Beyotime Institute of Biotechnology, Haimen, China) and goat anti-rabbit IgG labeled with cyanine (Cy)3 (1:200; cat. no. P0183; Beyotime Institute of Biotechnology) at room temperature for 3 h. Hoechst 33258 (cat. no. C1017; Beyotime Institute of Biotechnology) was used to stain the nucleus at room temperature for 5 min. Following 3 washes (5 min/wash) at room temperature with PBS, the slides were then mounted with antifade mounting medium (cat. no. P0126; Beyotime Institute of Biotechnology), sealed at the edges with nail enamel and naturally dried at room temperature for 1 h. The whole process was performed in darkness. The prepared samples were preserved in a light-tight box at −20°C prior to observation. Samples were observed by laser scanning confocal microscope (LSCM; Olympus FV1000; Tokyo, Japan). Images were captured under ×400 or ×600 magnification.

### Hematoxylin and eosin staining (HE)

Cells seeded on coverslips were fixed in 95% ethanol (pre-cooling) at 4°C for 20 min. All steps below were then performed at room temperature. Following washing with tap water for 40 sec, the coverslips were dipped into hematoxylin solution containing 0.5% (m/v) hematoxylin, 5% ethanol, 10% (m/v) KAl(SO~4~)~2~, 0.25% (m/v) HgO for 5 min, washed with tap water for 5 sec, differentiated in 75% ethanol containing 0.5% HCl for 5--10 sec, and then washed with tap water again for 15 min. The coverslips were then stained with eosin Y solution containing 0.5% (m/v) eosin Y and 20% ethanol for 1 min, followed by dehydrating with two changes of 95% ethanol and two changes of 100% ethanol for 5 min each. Samples were then cleared with two changes of xylene for 5 min each, and mounted with neutral balsam. Once the mounting medium dried, samples were observed under a light microscope. Images were captured under ×400 magnification.

### Statistical analysis

Data reported in the graphs represent the averages of three independent experiments, and are presented as the mean ± standard deviation. Data were analyzed by GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA, USA) using two-way analysis of variance followed by Tukeys multiple comparison test.

Results
=======

### Differentially expressed NMPs were identified using 2D gel electrophoresis

In order to systematically analyze the alteration in the protein expression profile in the nuclear matrix during curcumin-induced apoptosis, selectively extracted NMPs were separated using 2D gel electrophoresis. The concentrations of protein spots were analyzed using PDQuest 8.0 software. Protein spots with a fold change \>2 were subjected to MALDI-TOF-MS analysis ([Fig. 1A](#f1-ol-0-0-7283){ref-type="fig"}). The protein spot 36 was identified as protein 14-3-3ε. As presented in [Fig. 1B and C](#f1-ol-0-0-7283){ref-type="fig"}, the quantity of spot 36 was decreased markedly following treatment with curcumin, compared with the control group. The identification is presented in [Fig. 2](#f2-ol-0-0-7283){ref-type="fig"} and [Table I](#tI-ol-0-0-7283){ref-type="table"}. Protein score was 258 (a score ≥66 indicates successful identification).

### Expression of 14-3-3ε is downregulated following curcumin treatment

To determine whether curcumin may regulate the expression of 14-3-3ε, western blot analysis was performed to detect the expression level of 14-3-3ε. As presented in [Fig. 3](#f3-ol-0-0-7283){ref-type="fig"}, following treatment with curcumin for 24 h, the expression level of 14-3-3ε was significantly decreased in MG-63 cells (P\<0.001), as compared with that in control cells. Notably, a truncated fragment was identified with the downregulation of 14-3-3ε. To validate whether the detected fragment was the 14-3-3ε protein, a rabbit antibody ([Fig. 3A](#f3-ol-0-0-7283){ref-type="fig"}) and a mouse monoclonal antibody ([Fig. 3B](#f3-ol-0-0-7283){ref-type="fig"}) were used for an immunoblot assay, and the truncated fragment was detected using the two antibodies. Thus, it was deduced that this fragment was a specific short term of 14-3-3ε (14-3-3ε-S).

### Fluorescence intensity of 14-3-3ε in the nuclear matrix of apoptotic cells is decreased following treatment with curcumin

Commonly, the cellular localization of proteins decides their functions ([@b29-ol-0-0-7283]--[@b31-ol-0-0-7283]). Using immunofluorescence labeling technology enabled the identified of the localization of 14-3-3ε in MG-63 cells and the nuclear matrix-intermediate filament system, prior to and following curcumin-induced apoptosis. As presented in [Fig. 4A](#f4-ol-0-0-7283){ref-type="fig"}, MG-63 cells exhibited irregular morphology, the majority of which were long spindle- or multiple angle-shaped with sheet or horn-like processes on the cell surface, and large off-center nuclei. Results from the immunofluorescence assay ([Fig. 4B](#f4-ol-0-0-7283){ref-type="fig"}) demonstrated that 14-3-3ε was distributed evenly throughout MG-63 cells. Following treatment with curcumin, the cells shrunk and became round in shape, and the connections between cells and the processes on the cell surface disappeared. Nucleus staining revealed karyopyknosis and more intense staining, as compared with the control cells ([Fig. 4A](#f4-ol-0-0-7283){ref-type="fig"}). Fluorescence microscopy demonstrated that the fluorescence intensity in the nucleus was weaker ([Fig. 4B](#f4-ol-0-0-7283){ref-type="fig"}), compared with that in the cytoplasm, indicating a decreased level of 14-3-3ε in the nucleus.

As presented [Fig. 4C](#f4-ol-0-0-7283){ref-type="fig"}, the nuclear matrix-intermediate filament (NM-IF) system in MG-63 cells underwent significant alteration during curcumin-induced apoptosis. Nuclear matrix connected with intermediate filaments through the nuclear lamina to form an integrated system. In cells of the control group, intermediate filament was extended between the edge of the nuclear lamina and the periphery of the cell to form an intact network structure. In addition, the filaments were arranged regularly, and gradually became sparse from the perinuclear region to the edge of the cell. The nuclear lamina was thick and intensely stained. Fiber hierarchy of nuclear matrix was compact with deep staining. Following treatment with curcumin, the nuclear matrix-intermediate filament system tended to be fractured, disordered and lightly stained. The intermediate fiber was sparse and discontinuous. The nuclear lamina was thin and the fiber hierarchy of the nuclear matrix was sparse. The cytoskeleton was no longer intact. Immunofluorescence staining results ([Fig. 4D](#f4-ol-0-0-7283){ref-type="fig"}) revealed that the fluorescence intensity of 14-3-3ε in the nuclear matrix of apoptotic cells was decreased, compared with that in normal cells.

### Apoptosis-associated proteins are co-localized with 14-3-3ε in MG-63 cells

The expression level and localization of 14-3-3ε in MG-63 cells were significantly altered following treatment with curcumin. To validate that 14-3-3ε was associated with apoptosis, a confocal laser-scanning double immunofluorescence staining method was used to observe the localization association between 14-3-3ε and apoptosis-associated proteins, including Bcl-2, Bax, p53, RB and c-FOS. In [Fig. 5A-C](#f5-ol-0-0-7283){ref-type="fig"}, 14-3-3ε was labeled with red fluorescent dye Cy3, whereas Bax, Bcl-2 and p53 were labeled with green fluorescent FITC. In [Fig. 5D and E](#f5-ol-0-0-7283){ref-type="fig"}, 14-3-3ε was labeled with FITC, and RB and c-FOS protein were labeled with Cy3. Orange fluorescence indicated a co-localization association between two proteins. The results of the present study demonstrated that 14-3-3ε was primarily distributed in the cytoplasm with a centralized distribution in the area adjacent to the nucleus. The distribution of the protein in the nucleus was decreased relative to that in the cytoplasm. Following treatment with curcumin, 14-3-3ε distribution remained primarily in the cytoplasm, but in the nucleus the distribution was weakened.

As presented in [Fig. 5A-C](#f5-ol-0-0-7283){ref-type="fig"}, Bax, Bcl-2 and p53 were primarily distributed in the cytoplasm, and these proteins were at low levels in the nucleus. Among these proteins, Bcl-2 revealed an intense fluorescent stain in a concentrated area. The results from the merged images demonstrated orange fluorescence in the cytoplasm for the three proteins, indicating that 14-3-3ε was co-localized with Bax, Bcl-2 and p53 in the cytoplasm. Following treatment with curcumin, Bax and Bcl-2 remained in the cytoplasm, the fluorescence intensity of Bax was increased compared with that in control cells and the concentrated distribution of Bcl-2 fluorescence was no longer visible. The distribution of p53 remained primarily in the cytoplasm, but there was an increase of fluorescence in the nucleus, as compared with that in control cells. No orange fluorescence was observed in the merged images, which indicated that co-localization of 14-3-3ε with Bax, Bcl-2 and p53 was decreased or non-existent following curcumin treatment.

The co-localization association between 14-3-3ε and c-FOS and RB is presented in [Fig. 5D and E](#f5-ol-0-0-7283){ref-type="fig"}. c-FOS was primarily distributed in the cytoplasm, with a limited amount in the nucleus. RB was restricted to the nucleus, with the exception of the nucleolus. The superimposition demonstrated that 14-3-3ε was co-localized with c-FOS in the cytoplasm. However, for RB, there was no apparent co-localization association between 14-3-3ε and RB. Compared with the control group, after treatment with curcumin, the fluorescence intensity of c-FOS was identified to be significantly decreased in the cytoplasm, but in the nucleus the fluorescence intensity of c-FOS was increased. The fluorescence intensity of RB was increased with no localization alteration. The superimposition demonstrated that there was no co-localization between 14-3-3ε and RB, and the co-localization association between 14-3-3ε and c-FOS was significantly weakened.

Discussion
==========

NMPs are involved with a number of different activities in the nucleus including DNA replication and synthesis, RNA transcription and processing, and gene expression regulation; thus, NMPs serve an important function in cells ([@b22-ol-0-0-7283]). Identifying the nuclear localization of 14-3-3ε may demonstrate that it exhibits a novel regulatory role in MG-63 cells. In the present study, 14-3-3ε was identified to be a nuclear matrix-associated protein using 2D gel electrophoresis. In addition, western blot analysis validated the existence of 14-3-3ε in the nuclear matrix, and the expression and localization of 14-3-3ε in the nuclear matrix was observed using immunofluorescent labeling. Liu *et al* ([@b7-ol-0-0-7283]) identified that 14-3-3ε was primarily located in the nucleus of SW480 colon cancer cells, with a perinuclear translocation induced by triptolide. There are a limited number of studies which have focused on the localization of 14-3-3ε. Our early studies focusing on apoptosis of MG-63 cells had identified that important functional proteins including nucleophosmin, prohibitin and heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 were located in the nuclear matrix ([@b32-ol-0-0-7283]). By associating with the nuclear matrix, nucleophosmin, prohibitin and hnRNP A2/B1 served functions in regulating cell carcinogenesis and apoptosis ([@b32-ol-0-0-7283]). Thus, the localization of 14-3-3ε in the nuclear matrix indicated that it served an unknown function in the regulation of cell processes, which required further study.

Expression levels of important functional proteins are typically altered during cell apoptosis ([@b33-ol-0-0-7283]--[@b35-ol-0-0-7283]). The results of the present study, using 2D analysis, revealed a significant decrease of 14-3-3ε in the nuclear matrix of apoptotic MG-63 cells. This alteration indicated that 14-3-3ε, as an important nuclear matrix-associated protein, was associated with the regulation of apoptosis in MG-63 cells. In addition, western blot analysis demonstrated that the expression level of 14-3-3ε was decreased following curcumin treatment, in a time-dependent manner. However, the expression level of 14-3-3ε-S demonstrated an opposite trend, as this increased with treatment duration. Results from immunofluorescence assays demonstrated a decrease in fluorescence intensity of 14-3-3ε in the nuclear matrix of apoptotic cells. Therefore, the results of the present study demonstrated a decrease in the expression level of 14-3-3ε. Nagappan *et al* ([@b5-ol-0-0-7283]) validated that downregulation of 14-3-3ε induced apoptosis in AGS gastric cancer cells. Consistently, a study by Wu *et al* ([@b36-ol-0-0-7283]) revealed that rosiglitazone-induced upregulation of 14-3-3ε decreased the apoptosis of neuronal cells. These studies indicated that the downregulation of 14-3-3ε was an upstream event of apoptosis, rather than a downstream one. Notably, the results of the present study revealed that the expression level of 14-3-3ε-S was increased along with apoptosis, which should be additionally investigated.

The regulation of cell apoptosis is a complex process ([@b37-ol-0-0-7283]). Thus, we hypothesized that the interactions between 14-3-3ε and a number of additional apoptosis-associated proteins may be involved in cell apoptosis. Using LSCM, it was observed in the present study that 14-3-3ε was co-localized with Bax, Bcl-2, p53 and c-FOS in the cytoplasm of MG-63 cells. Following treatment with curcumin, their co-localization was decreased. To the best of our knowledge, only Bcl-2-associated death promoter has been identified to bind to 14-3-3ε, resulting in its retention in the cytoplasm and suppression of apoptosis ([@b38-ol-0-0-7283]). Our group hypothesized that Bax may bind to 14-3-3ε, thus impairing its pro-apoptotic ability. Previous studies have demonstrated that 14-3-3σ, τ, ζ and ε may bind to Bax ([@b18-ol-0-0-7283],[@b39-ol-0-0-7283]), but the interaction between 14-3-3ε and Bax requires validation. The ratio between Bax and Bcl-2 is a key factor to determine whether apoptosis occurs or not ([@b40-ol-0-0-7283]). The results of the present study demonstrated that 14-3-3ε was co-localized with Bax and Bcl-2, which indicated that 14-3-3ε may regulate the progress of apoptosis by influencing the ratio between Bax and Bcl-2. As an important transcription factor, p53 may regulate the expression of multiple pro-apoptotic genes including Bax and Fas, thereby serving a pro-apoptotic function ([@b41-ol-0-0-7283],[@b42-ol-0-0-7283]). Gbormittah *et al* ([@b43-ol-0-0-7283]) demonstrated a co-expression and co-localization association between 14-3-3ε and p53, using chromosome gene mapping. To the best of our knowledge, there are no other studies which demonstrated an association between 14-3-3ε and p53. In the present study, 14-3-3ε was identified to be co-localized with p53 in the cytoplasm in MG-63 cells, which indicated that the interaction between 14-3-3ε and p53 may serve a function in the apoptosis of MG-63 cells. c-FOS is a proto-oncogene which has been identified to be associated with the occurrence, invasion and metastasis of multiple types of tumor ([@b44-ol-0-0-7283]). In some studies, c-FOS was identified to be involved with the death of nerve cells ([@b45-ol-0-0-7283]--[@b47-ol-0-0-7283]). In addition, 14-3-3ε has been demonstrated to serve a function in the death of nerve cells ([@b48-ol-0-0-7283]--[@b50-ol-0-0-7283]). Although, to the best of our knowledge, no studies have identified an association between 14-3-3ε and c-FOS, their co-localization suggests that these two may interact. Co-localization of 14-3-3ε with the aforementioned apoptosis-associated proteins indicated that 14-3-3ε may participate in the regulation of apoptosis of MG-63 cells.

The present study demonstrated that 14-3-3ε exists in the nuclear matrix of MG-63 cells and is downregulated during curcumin-induced apoptosis. Furthermore, 14-3-3ε is co-localized with Bax, Bcl-2, p53 and c-FOS in the cytoplasm of MG-63 cells, and these co-localizations are decreased following curcumin treatment. These results indicated that 14-3-3ε is a nuclear matrix-associated protein and it may serve a role in the regulatory events of apoptosis.
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![Two-dimensional gel electrophoresis of NMPs in MG-63 cells treated with or without curcumin. (A) Two-dimensional 11 cm, pH 4--7 immobilized pH gradient strips were used for isoelectric focusing. Protein spot 36 was identified as 14-3-3ε. (B) Partial enlargement image of spot 36. (C) Quantification of spot 36 in Con and CUR; maximal value was 7,681 PPM. Using PDQuest software, spot quantity=spot height × π × σ~x~ × σ~y~ (INT\*area). PPM, parts per million; Con, control; CUR, curcumin-treated; INT, intensity. Normalization method, total quantity in valid spots.](ol-15-01-0338-g00){#f1-ol-0-0-7283}

![Identification of 14-3-3ε. (A) Peptide mass fingerprinting of spot 36. (B) MASCOT search results of spot 36. Spot 36 demonstrated a protein score of 258, which was substantially higher than the threshold of 66, for identification as 14-3-3ε. Intens (a.u.), intensity (arbitrary units).](ol-15-01-0338-g01){#f2-ol-0-0-7283}

![Western blot analysis of 14-3-3ε expression levels at 0, 12, 24 and 36 h following treatment with curcumin. (A) 14-3-3ε expression levels were detected with a rabbit anti-14-3-3ε antibody. (B) 14-3-3ε expression levels were detected using a mouse anti-14-3-3ε antibody. (C) Expression levels of 14-3-3ε were quantified using Quantity One software. Expression levels relative to GAPDH were normalized to the 14-3-3ε level at 0 h and analyzed using two-way analysis of variance (n=3, mean ± standard error). \*\*\*P\<0.001 and \*\*\*\*P\<0.0001 vs. 14-3-3ε, ^†^P\<0.05 and ^††^P\<0.01 vs. 14-3-3ε-S at 0 h. ns, no significance; 14-3-3ε-S, truncated specific short term of 14-3-3ε; \*for 14-3-3ε and † for 14-3-3ε-S.](ol-15-01-0338-g02){#f3-ol-0-0-7283}

![Localization of 14-3-3ε in MG-63 cells and NM. (A) HE staining of MG-63 cells. (B) IF. The red fluorescence presented localization of 14-3-3ε in whole MG-63 cells. (C) Coomassie brilliant blue staining of the NM-IF system. (D) IF. The green fluorescence demonstrated localization of 14-3-3ε on NM-IF. The blue fluorescence presented the nucleus. NM, nuclear matrix; IF, intermediate filament; HE, hematoxylin and eosin; Con, control; CUR, curcumin-treated.](ol-15-01-0338-g03){#f4-ol-0-0-7283}

![Laser-scanning confocal microscopy revealed the co-localization of 14-3-3ε with apoptosis-associated proteins. (A) Co-localization of 14-3-3ε with Bax. (B) Co-localization of 14-3-3ε with Bcl-2. (C) Co-localization of 14-3-3ε with P53. Magnification, ×400, with 14-3-3ε labeled with red Cy3 and Bax, Bcl-2 and p53 labeled with green FITC. (D) Co-localization of 14-3-3ε with c-FOS. (E) Co-localization of 14-3-3ε with RB. Magnification, ×600, with 14-3-3ε labeled with green FITC and c-FOS and RB labeled with red Cy3. Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated-X protein; RB, retinoblastoma; FITC, fluorescein isothiocyanate; Cy, cyanine; Con, control; CUR, curcumin-treated.](ol-15-01-0338-g04){#f5-ol-0-0-7283}

###### 

Identification of 14-3-3ε.

  Parameter               Value
  ----------------------- -----------
  Spot no.                36
  Identified protein      14-3-3ε
  Gene symbol             YWHAE
  NCBI accession number   NP_006752
  Mass, Da                29,326
  pI                      4.63
  Coverage, %             47
  Matching peptides       16
